Statement from Acting FDA Commissioner Ned Sharpless, M.D., and Janet Woodcock, M.D., Director of the Center for Drug Evaluation and Research, on steps to make health care professional and patient labeling information for prescription medications consistent and clear

The FDA is committed to making sure that health care professionals and patients have up-to-date, accurate and actionable information about prescription medications so that informed treatment decisions can be made. We recognize that the choice of which medication to use, if any, for a particular patient is often a complex decision. These decisions involve a number of factors, such as assessing the progression of the disease or condition; looking at the other medications being taken; evaluating the ability of the patient to follow treatment regimens and instructions to ...

Read More